Viewing Study NCT01382706


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2026-01-13 @ 3:02 PM
Study NCT ID: NCT01382706
Status: TERMINATED
Last Update Posted: 2025-10-09
First Post: 2011-06-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder
Sponsor: University of Southern California
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Bladder Cancer View
None Stage III Bladder Cancer View
None Stage IV Bladder Cancer View
None Transitional Cell Carcinoma of the Bladder View
Keywords: